Vắc xin viêm màng não B đầu tiên được phê chuẩn
Liên minh châu Âu chấp thuận chấp nhận cho phép hãng dược Thụy Sĩ Novartis điều chế, sản xuất loại vắc xin đầu tiên ngừa bệnh viêm màng não B.
4bqkUUVE4buMxajhu4I6OkFDKnJSO8Wow5RD4bqm4butw4zhu4xEMVLhu6hEIFLhu5bGr0TGr0bhu6hQROG7qEnhu6pE4bqpRMOVTSxEO1Lhu5bhu6hEw5U+PeG7jEQqUeG7lkThu4xRLE/hu6jhuqQvUUXhuqbhuqQqROG7jMWo4buCOjpBQypmw5Thu4Lhu45D4bqmalLhu5bhu6hExq9S4buoUUThu4xRSyxE4bqzLEThu4xRTCpEO1EsTuG7qEThu4xRTCpE4buoUU7hu6hE4buMUeG7qkQqUeG7kCpEUUnhu6hQROG7jj494buMRHJRKDJEccOZRGzhu6og4buCPztSOkTDlVLhu5osROG7jFHGoOG6sEQ6SOG7qEQxLEw7RMWo4buqR1JEIMOM4buMRDFS4buoRMOVTSxEO1Lhu5bhu6hE4buoUH3hu4JEw5Lhu5zhu6hRRCBS4buWxq9Exq9G4buoUEThu6hJ4buqROG6qeG6tuG6pC8q4bqm4bqkKkThu4zFqOG7gjo6QUMq4bqp4buq4buOMkPhuqbhu63DjOG7jEQxUuG7qEThurrhuqvGr8OU4buo4bqpROG7jOG7sEQ74buW4buoRDtRPuG7uOG7qFBExq9HUkTFqEZEIMOM4buMRDFS4buoROG6qcOUMTrDlD/hu6pEw5Xhu6JEKlHhu6zhu6hQROG7qFB94buCRCBS4buWxq9Exq9G4buoUEThu6hJ4buqROG6qUThu4wp4buCRFFJ4buoUEThu44+PeG7jEQqUU/Gr0Rs4buqIOG7gj87UjpEclEoMkRxN0TDlUlEw5U+PeG7jEThu4xMKkQqUeG7kCpEOl1E4buOKOG7qFBEO0dSRDjhu6hR4bq2ROG7rcOM4buMRDFS4buoRCBS4buWxq9Exq9G4buoUEThu6hJ4buqROG6qURQUi4qRFFG4buoUEThu6hQRuG7qEThu6hQPiNS4bqwRDs/4buq4buoUETDleG7sEThu4xRKUQyxqAsRMWoRkQ7P+G7mETDlMavROG7plFY4buoUETDklVEO11EIOG7quG7qFBEUeG7quG7iOG7jEQ74bu04buoRFFHUkQ6e+G7jEThu6ZRVsOUROG7juG7qkQgUuG7lsavRMavRuG7qFBE4buoSeG7qkThuqnhurbhuqQvKuG6puG6pCpE4buMxajhu4I6OkFDKuG6qeG7quG7jjJD4bqm4butw4zhu4xEMVLhu6hE4bqpw5QxOsOUP+G7qkTDlT494buMRDHDlMavRMWoRkThu63DjOG7jEQxUuG7qEQgUuG7lsavRMavRuG7qFBE4buoSeG7qkThuqlEw5VNLEQ7UuG7luG7qETDlT494buMRCpR4buWROG7jFEsT+G7qOG6tuG6pC8q4bqm4bqkKkThu4zFqOG7gjo6QUMq4bqp4buq4buOMkPhuqZjPj3hu4xEw5JSxqA74bqwRFFS4buc4buoRCDDk+G7qEThu4xRPuG7gkThu4zhu7BExajhu6pHUkQgw4zhu4xEMVLhu6hE4buoRuG7qkTDlT494buMRCpR4buWROG7jFEsT+G7qEThu4zhu7BEO1Hhu6JE4buoUMON4buoROG7qFB94buCRD/hu7Lhu6hQRD9JUkThu4zDjeG7qETDkuG7nOG7qFFEIFLhu5bGr0TGr0bhu6hQROG7qEnhu6pE4bqp4bqwRMav4buyO0TFqOG7qkdSRCBS4buWxq9Exq9G4buoUEThu6hJ4buqRMOV4buI4buMRMOSUuG7nDvhurbhuqQvKuG6puG6pCpE4buMxajhu4I6OkFDKuG6qeG7quG7jjJD4bqm4butUuG7lsavRMavRuG7qFBE4buoSeG7qkThuqlE4buO4buqRCBSROG7plEsT+G7qERQSzJEP+G7guG6sEThu47Dk+G7qETDlcag4buoRDtU4buoUUQ7P0fhu6hQRCBS4buWxq9ExahAKkTGr0bhu6hQRMavVuG7qFBEw5Lhu4Lhu6pEw5Lhu67hu4xEJizhu4Lhu6hRROG7qEnhu6pEIEZEOykyRDpZ4buoUOG6tkThuqvDjeG7qETDkuG7nOG7qFFE4buM4buwRDtR4buiRFBLMkQ7XUQg4buq4buoUEQ7P+G7quG7qFBEIOG7rOG7qFBEw4nhurpEUFIjRCBGRDs/4buYRDrhu7hEOlLhu6hRRMWoRkTDlVlSRDs+PeG7qFBE4buM4buwROG7qFAsMkThu4zhu7hE4buM4buC4buqROG7qFFMO+G6tkTEqVHhu6pI4buoUERFxJDDgEThu6hQPiNSRMavw4zhu4xEw5Lhu5zhu6hRRMOSVUQ7XUQg4buq4buoUEThu4xR4buqROG7jiFEw5U+PeG7jETDlVLhu5osRDs/VUQ7UVPhu4xRRFE9KuG6tkRyP+G7quG7qFBE4bumUVJEw5Xhu7DhurBE4buM4buwROG7plHhu6pI4buoUETDicSQw4BEw5Lhu5zhu6hRROG7qFFL4buoRDssMkRQUiJEw5U+PeG7jETGr0fhu6hQRDpZ4buoUEThu6hRPuG7qFBEOuG7lEQqUUhSRFDhu4Thu6hRROG7jFFVLERRTixEJixIROG7qFBRUuG7lsavRDs/4buu4buoUOG6sEThu4xRxKjhu6hQRFFH4buoROG7qFE+RDvhu7Thu6hEO1E+4bu44buoUEThu6hJ4buqRCBGROG7plFSxqDGr0Q7UVPhu6hR4bq24bqkLyrhuqbhuqQqROG7jMWo4buCOjpBQyrhuqnhu6rhu44yQ+G6pmzhu6og4buCPztSOkThu4xR4buqRMOSUsagO0Qgw4zhu4xEMVLhu6hEIFLhu5bGr0TGr0bhu6hQROG7qEnhu6pE4bqpROG6qcOUMTrDlD/hu6pE4buM4buwRDvhu4Thu4xE4buOKOG7qFBEKlEoROG7qFE+RDpZO0QgRkTDlVZEO0dSROG7jFHhu7ZEO1Lhu5bGr+G6tuG6pC8q4bqm4bqkKkThu4zFqOG7gjo6QUMq4bqp4buq4buOMkPhuqbhuqBE4butUuG7lsavRMavRuG7qFBE4buoSeG7qkTFqEZEw5Lhu5zhu6hRROG7qFFS4buexq9EOz8h4buoUEThu4wp4buCRMavRuG7qFBE4buoSeG7quG6sEThu6hQLDLhu5bhu6hE4buoUUvhu6hE4buM4buwRDtR4buiROG7juG7qkQgUkQ7PyHhu6hQRFHhu4IyRDpS4buWLEQgUkQ7PyHhu6hQ4bq2RGPhu4JEOllE4buM4buE4buMRDs/PiPhu6hQRFE9KkQgUkQ7PyHhu6hQRFHhu4IyRDpS4buWLEQgUkQ7PyHhu6hQRDt9RCAh4buoUETGrzxSRFHhu67hu6hQRDFLxq9E4buoUU4qRCBG4buqRMavRuG7qFBE4buoSeG7qkQgRkRQSzJEIFLhu5bGr0TGr0bhu6hQROG7qEnhu6rhurZE4bqp4buc4buoUUQ7UT4j4buoUEQxSDJEP+G7gkQkRDs/4buYRMOUxq/hurBE4buoUT7hu6hQROG7qFA+I1JExahA4buoROG7jDzhu6hQROG7jOG7sEQ7UeG7okTDklVE4buoUVLhu57Gr0TDkuG7nOG7qFFE4buoRjLhurbhuqQvKuG6puG6pCpE4buMxajhu4I6OkFDKuG6qeG7quG7jjJD4bqmclHDlOG7qkQg4buoxq/DlOG7jlLhu4LhuqQvKuG6pg==